relestat 0.5 mg/ml collyre sol.
abbvie sa-nv - chlorhydrate d'epinastine 0,5 mg/ml - eq. epinastine 0,436 mg/ml - collyre en solution - 0,5 mg/ml - chlorhydrate d'epinastine 0.5 mg/ml - epinastine
alphagan 0.2 % collyre sol. flac. compte-gouttes
abbvie sa-nv - tartrate de brimonidine 2 mg/ml - eq. brimonidine 1,3 mg/ml - collyre en solution - brimonidine
aluvia, 200mg/50mg, comprimé pelliculé/ film coated tablet, b/120
abbvie deutschland gmbh & co.kg - lopinavir + ritovanir - comprimé pelliculé/ film coated tablet - 200mg/50mg
aluvia®, 100mg/25 mg, comprimé pelliculé/ film coated tablet, b/60
abbvie deutschland gmbh & co.kg - lopinavir + ritovanir - comprimé pelliculé/ film coated tablet - 100mg/25 mg
norvir ®, 100 mg, comprimé pelliculé/ film coated tablet, b/60
abbvie deutschland gmbh & co.kg - ritonavir - comprimé pelliculé/ film coated tablet - 100 mg
tronothane, 1%, gel pour application locale, t/30 g
abbvie ltd - pramocaine - gel pour application locale - 1%
skyrizi solution
abbvie corporation - risankizumab - solution - 90mg - risankizumab 90mg - misc. skin and mucous membrane agents
skyrizi solution
abbvie corporation - risankizumab - solution - 150mg - risankizumab 150mg - misc. skin and mucous membrane agents
skyrizi solution
abbvie corporation - risankizumab - solution - 150mg - risankizumab 150mg - misc. skin and mucous membrane agents
skyrizi solution
abbvie corporation - risankizumab - solution - 360mg - risankizumab 360mg